Increasing awareness and knowledge of Alpha-gal Syndrome in the United States

The purpose of this NOFO is to improved awareness and knowledge of alpha-gal syndrome (AGS) in the United States. AGS is an emerging condition and is not nationally notifiable. This NOFO seeks to improve AGS surveillance, patient care, and public awareness and understanding. The NOFO strategies are to 1) SHARE - Formation of a network of AGS professionals to disseminate latest knowledge of AGS among stakeholders, including public health agencies, academic researchers, and advocacy groups, in order to improve patient care for AGS and the public health response. 2) EDUCATE - Create AGS communications targeted at the general public, AGS patients, or persons at higher risk for tick encounters (outdoor enthusiasts, dog owners, outdoor workers, etc.). Create communications targeted at healthcare providers including educational resources and training. 3) TRACK - Conduct active or enhances public health surveillance for AGS. This strategy could involve patient populations or geographical locations with limited access to specialized healthcare provider care.

• NAICS93.084

• ck-26-0193_forPublication.pdf

  application/pdf381 KBNot yet available
• ck-26-0193_forPublication_Mod1.pdf

  application/pdf623 KBNot yet available

• Centers for Disease Control - NCEZID
  gqx1@cdc.gov770-488-2756